Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient
Authors:
Open Access
- 1 January 2022
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Chronic Disease
- Vol. 13
Abstract
Arterial hypertension is one of the major causes of cardiovascular morbidity and mortality worldwide. Effective and sustained reduction in blood pressure is essential to reduce individual cardiovascular risk. In daily clinical practice, single-pill fixed-dose combinations of different drug classes are important therapeutic resources that could improve both treatment adherence and cardiovascular risk management by targeting distinct pathophysiological mechanisms. The aim of this practical narrative review is to help physicians choosing the right single-pill fixed-dose combination for the right patient in the daily clinical practice, based on the individual clinical phenotype and cardiovascular risk profile.Keywords
This publication has 131 references indexed in Scilit:
- A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazideVascular Health and Risk Management, 2013
- Valsartan/Amlodipine Compared to Nifedipine GITS in Patients with Hypertension Inadequately Controlled by MonotherapyAdvances in Therapy, 2013
- Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort studyCanadian Medical Association Journal, 2013
- Benefits of once-daily therapies in the treatment of hypertensionVascular Health and Risk Management, 2011
- Olmesartan/amlodipine: a review of its use in the management of hypertensionVascular Health and Risk Management, 2011
- The Association of Left Ventricular Hypertrophy with Metabolic Syndrome is Dependent on Body Mass Index in Hypertensive Overweight or Obese PatientsPLOS ONE, 2011
- Fixed-dose combination and chronic kidney disease progression: which is the best?Current Opinion in Nephrology and Hypertension, 2010
- Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive PatientsCirculation, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Adherence to MedicationNew England Journal of Medicine, 2005